Compare AEIS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEIS | CRL |
|---|---|---|
| Founded | 1981 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.0B |
| IPO Year | 1995 | 2000 |
| Metric | AEIS | CRL |
|---|---|---|
| Price | $253.24 | $220.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $230.70 | $198.17 |
| AVG Volume (30 Days) | 405.6K | ★ 666.4K |
| Earning Date | 02-11-2026 | 02-18-2026 |
| Dividend Yield | ★ 0.16% | N/A |
| EPS Growth | ★ 236.95 | N/A |
| EPS | ★ 3.81 | N/A |
| Revenue | $1,724,842,000.00 | ★ $4,023,704,000.00 |
| Revenue This Year | $22.67 | N/A |
| Revenue Next Year | $12.82 | $1.70 |
| P/E Ratio | $67.46 | ★ N/A |
| Revenue Growth | ★ 17.19 | N/A |
| 52 Week Low | $75.01 | $91.86 |
| 52 Week High | $259.46 | $228.88 |
| Indicator | AEIS | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 67.73 | 67.74 |
| Support Level | $201.56 | $214.11 |
| Resistance Level | $232.00 | $228.88 |
| Average True Range (ATR) | 9.65 | 7.10 |
| MACD | 3.52 | 0.32 |
| Stochastic Oscillator | 83.52 | 73.96 |
Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.